SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Advanced Biomedical Technologies Inc. – ‘SB-2’ on 1/12/07 – EX-5.1

On:  Friday, 1/12/07, at 8:52pm ET   ·   As of:  1/16/07   ·   Accession #:  1002014-7-29   ·   File #:  333-139986

6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/16/07  Advanced Biomedical Techs Inc.    SB-2        1/12/07    9:787K                                   Law Office of Con… PS/FA

Registration of Securities by a Small-Business Issuer   —   Form SB-2
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SB-2        Form SB-2 for Geostar Mineral Corporation           HTML    295K 
 2: EX-3.1      Articles of Incorporation                           HTML     19K 
 3: EX-3.2      Bylaws                                              HTML     49K 
 4: EX-4.1      Specimen Stock Certificate                          HTML     19K 
 5: EX-5.1      Opinion of Conrad C. Lysiak, Esq.                   HTML     16K 
 6: EX-10.1     Trust Agreement                                     HTML      9K 
 7: EX-23.1     Consent of Malone & Bailey, Pc                      HTML      8K 
 8: EX-23.2     Consent of Conrad C. Lysiak, Esq.                   HTML      8K 
 9: EX-99.1     Subscription Agreement                              HTML     11K 


EX-5.1   —   Opinion of Conrad C. Lysiak, Esq.


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Opinion of Conrad C. Lysiak, Esq.  

Exhibit 5.1

THE LAW OFFICE OF
CONRAD C. LYSIAK
601 West First Avenue, Suite 903
Spokane, Washington 99201
(509) 624-1475
FAX: (509) 747-1770
EMAIL: cclysiak@qwest.net

January 11, 2007

Securities and Exchange Commission
100 F Street N.E.
Washington, D. C. 20549

RE: Geostar Minerals Corporation

Gentlemen:

     Please be advised that I have independently verified each of the following and reached the following conclusions regarding the above offering:

     1. Geostar Minerals Corporation (the "Company") is a duly and legally organized and exiting Nevada state corporation, with its registered office located in Reno, Nevada and its principal place of business located in Surrey, British Columbia, Canada. The Articles of Incorporation and corporate registration fees were submitted to the Nevada Secretary of State's office and filed with the office on September 12, 2006. The Company's existence and form is valid and legal pursuant laws of the State of Nevada, its Constitution and reported judicial decisions interpreting those laws.

     2. The Company is a fully and duly incorporated Nevada corporate entity. The Company has one class of Common Stock at this time. Neither the Articles of Incorporation, Bylaws, and amendments thereto, nor subsequent resolutions change the non-assessable characteristics of the Company's common shares of stock. The Common Stock previously issued by the Company is in legal form and in compliance with the laws of the State of Nevada, its Constitution and reported judicial decisions interpreting those laws and when such stock was issued it was duly authorized, fully paid for and non-assessable. The common stock to be sold under this Form SB-2 Registration Statement is likewise legal under the laws of the State of Nevada, its Constitution and reported judicial decisions interpreting those laws and when such stock is issued it will be duly authorized, fully paid for and non-assessable.

     3. To my knowledge, the Company is not a party to any legal proceedings nor are there any judgments against the Company, nor are there any actions or suits filed or threatened against it or its officers and directors, in their capacities as such, other than as set forth in the registration statement. I know of no disputes involving the Company and the Company has no claim, actions or inquires from any federal, state or other government agency, other than as set forth in the registration statement. I know of no claims against the Company or any reputed claims against it at this time, other than as set forth in the registration statement.


  Securities and Exchange Commission
RE: Geostar Minerals Corporation
January 11, 2007
Page 2

     4. The Company's outstanding shares are all common shares. There are no liquidation preference rights held by any of the Shareholders upon voluntary or involuntary liquidation of the Company.

     5. The directors and officers of the Company are indemnified against all costs, expenses, judgments and liabilities, including attorney's fees, reasonably incurred by or imposed upon them or any of them in connection with or resulting from any action, suit or proceedings, civil or general, in which the officer or director is or may be made a party by reason of his being or having been such a director or officer. This indemnification is not exclusive of other rights to which such director or officer may be entitled as a matter of law.

     6. All tax benefits to be derived from the Company’s operations shall inure to the benefit of the Company. Shareholders will receive no tax benefits from their stock ownership, however, this must be reviewed in light of the Tax Reform Act of 1986.

     7. By directors’ resolution, the Company has authorized the issuance of up to 2,000,000 shares of common stock.

     The Company's Articles of Incorporation presently provide the authority to the Company to issue 100,000,000 shares of Common Stock, $0.00001 par value. Therefore, a Board of Directors’ Resolution which authorized the issuance for sale of up to 2,000,000 shares of common stock would be within the authority of the Company’s directors and the shares, when issued, will be validly issued, fully paid and non-assessable.

  Yours truly,

CONRAD C. LYSIAK
Conrad C. Lysiak

 

 

 

-2-



Dates Referenced Herein

This ‘SB-2’ Filing    Date    Other Filings
Filed as of:1/16/07None on these Dates
Filed on:1/12/07
1/11/07
9/12/06
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/13/21  Advanced Biomedical Techs Inc.    10-Q        7/31/21   37:2.3M                                   M2 Compliance LLC/FA
 6/21/21  Advanced Biomedical Techs Inc.    10-Q        4/30/21   36:1.5M                                   M2 Compliance LLC/FA
 3/22/21  Advanced Biomedical Techs Inc.    10-Q        1/31/21   35:1.6M                                   M2 Compliance LLC/FA
 1/29/21  Advanced Biomedical Techs Inc.    10-K       10/31/20   55:3.5M                                   M2 Compliance LLC/FA
 9/21/20  Advanced Biomedical Techs Inc.    10-Q        7/31/20   36:1.6M                                   M2 Compliance LLC/FA
 8/20/20  Advanced Biomedical Techs Inc.    10-Q/A      1/31/20   35:1.6M                                   M2 Compliance LLC/FA
Top
Filing Submission 0001002014-07-000029   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 1:36:55.1pm ET